| Project/Area Number |
24659144
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Pathological medical chemistry
|
|---|
| Research Institution | The University of Tokyo |
|---|
Principal Investigator |
NISHINO Takeshi 東京大学, 大学院・農学生命科学研究科, 特任教授 (40094312)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KUSANO Teruo 日本医科大学, 医学部, 助教 (30434129)
MIYAGAWA Takuya 東京大学, 大学院・農学生命科学研究科, 助教 (50596559)
|
|---|
| Project Period (FY) |
2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2012: ¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
|
|---|
| Keywords | 筋萎縮性側索硬化症 / キサンチン酸化還元酵素 / 抗痛風剤 / 活性酸素 / 抗痛風薬 / プリン代謝 |
|---|
| Research Abstract |
We orally administered recently introduced potent xanthine oxidoreductase inhibitors, whose mechanisms of inhibition are well characterized, to ALS G1H-G93A mice. The results of modelexperiments indicated that orally administered non-purine analogue XOR inhibitors significantly delaythe disease progression. The protective effect is suggested to be due to increased removal ofaggregated protein accompany with change in purine metabolism by the experiment with modelsystems.
|
